Our findings reveal a novel "bile acid-MMEC-muscle" axis in sarcopenia, where miR-135a-5p-mediated ABCB1 downregulation in MMECs disrupts the local bile acid milieu and impairs muscle regeneration, highlighting ABCB1 as a potential therapeutic target for aging-related muscle loss. The gene discussed is ABCB1; the disease is sarcopenia.